A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

NCT06321198 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

12

Enrollment

OTHER_GOV

Sponsor class

Conditions

Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)

Interventions

BIOLOGICAL: iMSC

Sponsor

Anhui Provincial Hospital

Collaborators

[object Object]